EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis

Stéphane Hilliquin, Olivier Fogel, Mathilde Tissier, Chahrazad Cherifi, Karim Ibrahim, Chayma Saadan, Camille Flageollet, Wilton Albeiro Gomez Henao, Judith Melki, Robert Olaso, Jean-François Deleuze, Brigitte Baroukh und 10 weitere

Annals of the Rheumatic Diseases · 2026

DOI: 10.1016/j.ard.2026.06.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Stéphane Hilliquin und 21 weiteren Autor:innen. Beteiligte Einrichtung: UMR-S 1333 Santé Orale, Institut National de la Santé et de la Recherche Médicale (INSERN), Université Paris Cité and Sorbonne Paris Nord, Montrouge,…. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing, N-Acetylglucosaminyltransferases, Bone Development. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence nationale de la recherche, Mylan, Assistance Publique - Hôpitaux de Paris.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Pathological ossification leading to spinal ankylosis is a hallmark of ankylosing spondylitis (AS), yet its molecular mechanisms remain poorly understood. We investigated the genetic basis and functional consequences of severe familial AS to identify pathways driving structural progression. METHODS: Genome-wide linkage analysis and whole-exome sequencing were performed in a multiplex family with severe AS. A heterozygous knock-in mouse carrying the identified EXTL3 variant was generated and characterized using microCT, histology, transcriptomics, primary osteoblast and chondrocyte cultures, and biochemical analyses of heparan sulfate (HS) metabolism. RESULTS: A rare missense variant in EXTL3, a key enzyme involved in HS biosynthesis, was identified in affected family members. Extl3mut/+ mice developed sacroiliac structural abnormalities, osteoid accumulation and early joint bridging, together with impaired trabecular bone architecture. Mechanistically, the mutation accelerated chondrocyte hypertrophy while delaying osteoblast maturation and mineralization. These changes were associated with activation of Wnt signalling, increased HS accumulation, enhanced heparanase expression and altered glycosaminoglycan homeostasis. Collectively, these findings identify EXTL3-mediated HS dysregulation as a novel mechanism linking abnormal bone remodelling to pathological ossification. CONCLUSIONS: Our study identifies EXTL3 as a genetic modifier of structural severity in AS and reveals a previously unrecognised role for HS metabolism in pathological ossification. These findings support a model in which HLA-B27 primarily confers disease susceptibility, whereas rare variants such as EXTL3 contribute to structural progression, highlighting HS-related pathways as potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spondylitis, AnkylosingN-AcetylglucosaminyltransferasesBone DevelopmentAnimalsHumansMiceFemaleMaleMutation, MissenseOsteoblastsPedigreeChondrocytesHeparan SulfateOssification, HeterotopicExome SequencingOsteogenesis

Substanzen

N-AcetylglucosaminyltransferasesEXTL3 protein, humanHeparan Sulfate

Autor:innen und Institutionen

  • UMR-S 1333 Santé Orale, Institut National de la Santé et de la Recherche Médicale (INSERN), Université Paris Cité and Sorbonne Paris Nord, Montrouge, France; Department of Rheumatology, Hôpital Cochin, Assistance publiq…
  • Department of Rheumatology, Hôpital Cochin, Assistance publique des Hôpitaux de Paris, Université Paris Cité, Paris, France; Laboratory of Tissue Homeostasis and Disease, Department of Development and Regeneration, Skel…
  • Department of Rheumatology, Hôpital Cochin, Assistance publique des Hôpitaux de Paris, Université Paris Cité, Paris, France; Immunoregulation Unit, Institut Pasteur, Université Paris Cité, Paris, France.
  • Glycobiology, Cell Growth and Tissue Repair Research Unit (Gly-CRRET), Université Paris-Est Créteil (UPEC), Créteil, France.
  • UMR-S 1333 Santé Orale, Institut National de la Santé et de la Recherche Médicale (INSERN), Université Paris Cité and Sorbonne Paris Nord, Montrouge, France.
  • Glycobiology, Cell Growth and Tissue Repair Research Unit (Gly-CRRET), Université Paris-Est Créteil (UPEC), Créteil, France; Laboratorio Internacional Glycobiology, Cell Growth and Tissue Repair Research Unit Universida…

Förderung

  • Agence nationale de la recherche
  • Mylan
  • Assistance Publique - Hôpitaux de Paris
  • UCB Group
  • Chugai Pharmaceutical
  • Société Française de Rhumatologie

Zitieren

APA

Hilliquin, S., Fogel, O., Tissier, M., Cherifi, C., Ibrahim, K., Saadan, C., Flageollet, C., Henao, W. A. G., Melki, J., Olaso, R., Deleuze, J. F., Baroukh, B., Chaussain, C., Rogge, L., Bianchi, E., Cruzeiro, M. D., Cornelis, F. M. F., Lories, R., Albanese, P., …, & Miceli-Richard, C. (2026). EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.06.031

Vancouver

Hilliquin S, Fogel O, Tissier M, Cherifi C, Ibrahim K, Saadan C, et al. EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.06.031

BibTeX
@article{Hilliquin2026,
  author = {Hilliquin, Stéphane and Fogel, Olivier and Tissier, Mathilde and Cherifi, Chahrazad and Ibrahim, Karim and Saadan, Chayma and Flageollet, Camille and Henao, Wilton Albeiro Gomez and Melki, Judith and Olaso, Robert and Deleuze, Jean-François and Baroukh, Brigitte and Chaussain, Catherine and Rogge, Lars and Bianchi, Elisabetta and Cruzeiro, Marcio Do and Cornelis, Frederique M F and Lories, Rik and Albanese, Patricia and Houard, Xavier and Bardet, Claire and Miceli-Richard, Corinne},
  title = {EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  doi = {10.1016/j.ard.2026.06.031}
}
Kostenlos starten →